What content formats work best for pharma internal communications?

Anthony Stackman ·

The content formats that tend to work best for pharma internal communications are short-form video, microlearning modules, interactive digital newsletters, and visual infographics — used in combination rather than in isolation. The right mix depends on your workforce profile, the complexity of the content, and how employees access communications day to day. Field-based teams have fundamentally different needs from those working at a fixed desk. The sections below address the most common format questions pharma internal comms teams are asking in 2026.

Why do traditional formats fall short in pharma internal comms?

Lengthy PDF briefings, email newsletters, and printed materials were built for a static, office-based workforce that no longer reflects how most pharmaceutical teams operate. They demand sustained attention, require desktop access, and rarely accommodate the scientific complexity or regulatory sensitivity of pharma content in a way that holds people’s interest.

Pharmaceutical organisations face a structural communications challenge that most other industries do not. A significant proportion of the workforce is field-based, moving across territories with limited time between appointments. The content itself is also inherently complex: clinical data, regulatory updates, market access shifts, and medical affairs briefings all require a level of precision that generic formats struggle to carry without either oversimplifying or overwhelming the reader.

Long-form documents also create compliance risks. When employees disengage from internal communications, they miss critical updates. In a regulated industry where medical, legal, and regulatory alignment is non-negotiable, low engagement is not just a communications problem — it is a governance problem. The formats pharma companies have traditionally relied on were designed for a different era of work and a different standard of attention.

What content formats work best for reaching field-based pharma employees?

For field-based pharma employees, the most effective internal communications formats are mobile-optimised microlearning, short video briefings, and push-notification-driven digital updates. They work because they are accessible on the move, consumable in under five minutes, and do not require a stable desk environment or sustained reading time.

Field medical and sales teams often have narrow windows between customer interactions. A two-minute video summarising a new product indication update, or a three-question knowledge check reinforcing a recent training module, fits naturally into that rhythm. Formats that require scrolling through a 12-page PDF do not.

Delivery mechanism matters just as much as format. Content that lives inside an app or mobile-first platform the team already uses for CRM or scheduling is far more likely to be consumed than content sent as an email attachment. The format and the channel are inseparable when designing for field-based employees. Treating them as separate decisions consistently undermines reach and retention.

How does video perform as an internal communications format in pharma?

Video performs strongly as an internal communications format in pharma, particularly for leadership updates, complex scientific explanations, and emotional or cultural messaging. It combines clarity with credibility, allowing medical or scientific content to be delivered with a nuance that text alone often loses.

Length and purpose are the key variables. Long-form video — anything over eight minutes without a clear structural reason for its duration — sees significant drop-off in internal settings. Short, purposeful video works differently. A three-minute explainer on a clinical trial outcome, delivered by a credible internal expert with clear on-screen annotations, can outperform a written briefing of equivalent information density.

Video also carries a tonal advantage that matters in pharmaceutical organisations. When a chief medical officer or global medical affairs lead delivers an update on camera, it conveys authority and context that a written summary cannot replicate. For sensitive communications — pipeline changes, restructuring announcements, or significant regulatory decisions — video gives leadership a human presence that builds trust rather than creating distance.

The practical barrier for many pharma internal comms teams is production quality. Employees now compare internal video to the polished content they consume in their personal lives. That does not mean every internal video needs broadcast production values, but shaky, poorly lit footage recorded on a laptop undermines the credibility of the message it carries.

What’s the difference between eLearning and microlearning for pharma teams?

eLearning refers to structured, often accredited digital learning programmes that can take 30 minutes to several hours to complete. Microlearning delivers focused knowledge in short bursts of two to ten minutes. For pharma internal communications, the distinction matters because each format serves a different purpose and a different moment in the employee journey.

eLearning is appropriate for onboarding, compliance certification, and deep product or therapeutic area training where regulatory sign-off requires documented completion. It is designed for situations where comprehensiveness is non-negotiable and where the organisation needs an auditable record that an employee has engaged with specific content to a defined standard.

Microlearning is built for reinforcement, agility, and reach. A field medical liaison who completed a full eLearning module on a new mechanism of action six months ago benefits more from a five-question refresher before a key account meeting than from being directed back to the original module. Microlearning also responds faster to change: when a label update or new clinical data emerges, a short microlearning asset can be deployed in days rather than the weeks it takes to revise a full eLearning course.

The most effective pharma internal comms programmes use both in sequence rather than treating them as alternatives. eLearning builds the foundation; microlearning maintains it.

Should pharma companies use infographics for internal scientific updates?

Yes — but only when the content has a clear visual logic. Infographics work best for data comparisons, process flows, trial design summaries, and mechanism of action overviews. They are not a universal solution for scientific complexity, and applying them indiscriminately can distort or oversimplify content that requires precision.

The strongest use cases are situations where relationships, sequences, or proportions are central to understanding. A competitive landscape comparison, a patient pathway diagram, or a summary of subgroup data from a clinical trial are all well-suited to visual treatment. A nuanced discussion of pharmacovigilance obligations or a regulatory submission timeline generally is not.

Design quality matters more than many internal comms teams expect. An infographic that uses inconsistent terminology, poorly sourced data, or visual metaphors that conflict with scientific accuracy creates more confusion than a well-written paragraph. In a regulated industry, the risk of misinterpretation is real. Internal infographics should go through the same medical, legal, and regulatory review process as external materials, even when intended purely for internal audiences.

How can pharma internal comms teams measure content format effectiveness?

Effectiveness is best measured through a combination of engagement metrics, knowledge retention assessments, and qualitative feedback. No single metric captures the full picture, but together they reveal which formats are reaching employees, which are being understood, and which are driving the behaviours the organisation needs.

Engagement metrics — open rates, video completion rates, click-through rates on digital newsletters, time-on-page for web-based content — tell you whether employees are accessing the content at all. They do not tell you whether it has been understood or applied.

Knowledge retention is better measured through post-content assessments, follow-up microlearning checks, or behavioural observation in the field. If a field team received a briefing on a new indication and continues to communicate the previous label in customer interactions, the format may have failed regardless of its open rate.

Qualitative feedback through pulse surveys, manager conversations, or focus groups adds the layer that quantitative metrics cannot provide: why employees engaged or disengaged, what felt relevant, and what felt like noise. Relying solely on analytics means missing the contextual intelligence that drives genuine format improvement.

The most meaningful measure is always behavioural alignment: are employees applying what they received? That requires connecting internal communications data to performance, compliance, and field activity data — something many pharmaceutical organisations are only beginning to do systematically in 2026.

How Wizzard helps pharma teams get internal communications right

We work with pharmaceutical and healthcare organisations to develop internal communications that are scientifically credible, creatively engaging, and built around how employees actually work. For pharma internal comms teams looking to move beyond legacy formats, we offer:

  • Strategic planning and channel mapping for field-based and office-based workforces
  • Short-form video and animation production designed for internal scientific content
  • Microlearning and digital learning asset development
  • Infographic and visual design with medical accuracy at the centre
  • Internal communications workshops and format audits

If your internal communications are not reaching the people who need them — or not driving the understanding and alignment your organisation requires — we would be glad to talk through what a more considered format strategy could look like for your team.

Related Articles